Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,649 | -11,709 | -45,990 | -19,976 | 33,572 |
| Depreciation Amortization | 1,911 | 3,129 | 3,273 | 3,936 | 5,205 |
| Income taxes - deferred | -1,239 | -7,407 | -346 | 0 | 0 |
| Accounts receivable | 294 | 2,572 | 46 | -172 | 187 |
| Other Working Capital | 1,301 | -2,085 | 638 | 2,478 | -741 |
| Other Operating Activity | -1,371 | -16,447 | 11,497 | -16,783 | -80,549 |
| Operating Cash Flow | $-19,753 | $-31,947 | $-30,882 | $-30,517 | $-42,326 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -358 | -1,415 | -1,126 | -2,526 |
| Net Acquisitions | N/A | 3,117 | N/A | N/A | -8,376 |
| Purchase Of Investment | N/A | N/A | N/A | -189 | 0 |
| Sale Of Investment | N/A | N/A | 3,215 | 0 | N/A |
| Other Investing Activity | 13,079 | 14,198 | 10,016 | -8,910 | 13 |
| Investing Cash Flow | $13,038 | $16,957 | $11,816 | $-10,225 | $-10,889 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 425 | 1,757 |
| Debt Repayment | -26 | -100 | -349 | -253 | -145 |
| Common Stock Issued | 5,127 | 63 | 6,000 | 59,707 | 32,997 |
| Common Stock Repurchased | -27 | -110 | -241 | -888 | 0 |
| Other Financing Activity | 24,791 | 764 | 364 | -3,600 | -1,827 |
| Financing Cash Flow | $29,865 | $617 | $5,774 | $55,391 | $32,782 |
| Exchange Rate Effect | -63 | 70 | 6 | 101 | 292 |
| Beginning Cash Position | 10,096 | 24,399 | 37,685 | 22,935 | 42,229 |
| End Cash Position | 33,183 | 10,096 | 24,399 | 37,685 | 22,088 |
| Net Cash Flow | $23,087 | $-14,303 | $-13,286 | $14,750 | $-20,141 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,753 | -31,947 | -30,882 | -30,517 | -42,326 |
| Capital Expenditure | -64 | -440 | -1,415 | -1,326 | -2,526 |
| Free Cash Flow | -19,817 | -32,387 | -32,297 | -31,843 | -44,852 |